Hua Medicine (Shanghai) Ltd.
HUMDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,074 | $3,121 | $3,000 | $4,257 |
| - Cash | $1,140 | $1,461 | $491 | $675 |
| + Debt | $300 | $168 | $98 | $72 |
| Enterprise Value | $235 | $1,827 | $2,607 | $3,654 |
| Revenue | $256 | $77 | $18 | $0 |
| % Growth | 234% | 335.3% | – | – |
| Gross Profit | $125 | $37 | $8 | $0 |
| % Margin | 48.7% | 48.8% | 43.7% | – |
| EBITDA | -$207 | -$167 | -$168 | -$310 |
| % Margin | -80.9% | -218.1% | -955% | – |
| Net Income | -$250 | -$211 | -$204 | -$331 |
| % Margin | -97.8% | -275.7% | -1,157.8% | – |
| EPS Diluted | -0.25 | -0.22 | -0.21 | -0.34 |
| % Growth | -13.6% | -4.8% | 38.2% | – |
| Operating Cash Flow | -$418 | $889 | -$230 | -$273 |
| Capital Expenditures | -$4 | -$10 | -$27 | -$67 |
| Free Cash Flow | -$422 | $880 | -$258 | -$340 |